75 related articles for article (PubMed ID: 10928047)
1. Bioadhesive peptides as potential anticancer drug carriers: activation via isopeptide deblocking by proteases.
Yamazaki Y; Tsuruga M; Gentsch B; Oka S; Kleinman HK; Mokotoff M
Anticancer Res; 2000; 20(3A):1381-4. PubMed ID: 10928047
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cleavage of diaminopimelate-containing isopeptides by leucine aminopeptidase and matrix metalloproteinases in tumors: application to bioadhesive peptides.
Yamazaki Y; Savva M; Kleinman HK; Oka S; Mokotoff M
J Pept Res; 1999 Feb; 53(2):177-87. PubMed ID: 10195455
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
[TBL] [Abstract][Full Text] [Related]
5. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
Marcucci F; Lefoulon F
Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
[TBL] [Abstract][Full Text] [Related]
6. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
[TBL] [Abstract][Full Text] [Related]
7. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
8. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
10. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
11. Identification of cell binding sites in the laminin alpha5-chain G domain.
Makino M; Okazaki I; Kasai S; Nishi N; Bougaeva M; Weeks BS; Otaka A; Nielsen PK; Yamada Y; Nomizu M
Exp Cell Res; 2002 Jul; 277(1):95-106. PubMed ID: 12061820
[TBL] [Abstract][Full Text] [Related]
12. Identification of neurite outgrowth active sites on the laminin alpha4 chain G domain.
Ichikawa N; Kasai S; Suzuki N; Nishi N; Oishi S; Fujii N; Kadoya Y; Hatori K; Mizuno Y; Nomizu M; Arikawa-Hirasawa E
Biochemistry; 2005 Apr; 44(15):5755-62. PubMed ID: 15823034
[TBL] [Abstract][Full Text] [Related]
13. Isopeptide method: development of S-acyl isopeptide method for the synthesis of difficult sequence-containing peptides.
Yoshiya T; Ito N; Kimura T; Kiso Y
J Pept Sci; 2008 Nov; 14(11):1203-8. PubMed ID: 18613286
[TBL] [Abstract][Full Text] [Related]
14. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
15. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
[TBL] [Abstract][Full Text] [Related]
16. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
17. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger.
Gopin A; Pessah N; Shamis M; Rader C; Shabat D
Angew Chem Int Ed Engl; 2003 Jan; 42(3):327-32. PubMed ID: 12548691
[No Abstract] [Full Text] [Related]
18. Substance P analogs containing alpha,alpha-dialkylated amino acids with potent anticancer activity.
Prasad S; Mathur A; Jaggi M; Singh AT; Mukherjee R
J Pept Sci; 2007 Aug; 13(8):544-8. PubMed ID: 17617800
[TBL] [Abstract][Full Text] [Related]
19. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexate.
Bai KB; Láng O; Orbán E; Szabó R; Köhidai L; Hudecz F; Mezö G
Bioconjug Chem; 2008 Nov; 19(11):2260-9. PubMed ID: 18959436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
